Skip to main content
Image
Image
Image
Cardiology
Vascular
CKM
Medical Education
Register for free
Log in
Heart Failure Academy
Lifelong learning for the heart failure community
Home
About
About Us
Topics
Featured Topics
Heart Failure Diagnosis and Imaging
Chronic Heart Failure Management
Acute and Advanced Heart Failure
Heart Failure Devices
Cardiomyopathies and Cardiac Amyloidosis
Heart Failure Comorbidities
Equity, Age, Sex, and Reproduction
Heart Failure Services, Prevention and Digital Health
Content Type
Videos
Articles
Broadcasts
Conferences
Podcasts
News
Events
Content for healthcare professionals only
Search
Image
Register for free
Log in
Back to Main Menu
View all platforms
Cardiology
Vascular
CKM
Medical Education
Content for healthcare professionals only
Breadcrumb
Home /
Images
Images
Filter by
Topics
- Any -
Imaging & Diagnostics
-Angiography
-CT/MRI
-Echocardiography & Ultrasound
-Nuclear
Inherited and Congenital Cardiac Conditions
-Congenital Heart Disease
Intervention
-Coronary Interventions
--Bifurcation
--Transradial Intervention
--Coronary Physiology
--Intravascular Imaging
-Drug-eluting balloons
-Peripheral Intervention
-Structural Intervention
MI/ACS
-STEMI
-Unstable Angina & NSTEMI
Prevention & Chronic Conditions
-Hypertension
--Hypertension Management
--Pulmonary Arterial Hypertension
-Angina
-Atherosclerosis and Hyperlipidemia
-Cardiac Rehabilitation Programmes
-Coronary Artery Disease
-Lifestyle
-Stroke
Vascular Disease and Surgery
-Venous Disease - General
--Pulmonary Embolism
---Deep Vein Thrombosis
-Aortic Disease - General
-Carotid Artery Disease
-Peripheral Artery Disease - General
-Vascular Intervention
Anticoagulation
-Antiplatelet
-DOAC
Cardiovascular Kidney Metabolic
-Cardiovascular Co-Morbidities
-Chronic Kidney Disease
-Diabetes
-Metabolic dysfunction-associated fatty liver disease (MAFLD)
-Obesity
Cardiovascular Surgery
COVID-19
CV Disease in Special Populations
-Cardio-oncology
-Paediatrics
-Pregnancy
Demographic
-Age
-Ethnicity
-Gender
Digital Health
Electrophysiology & Arrhythmia
-Atrial Arrhythmias
-Atrial Fibrillation
-Catheter Ablation of Cardiac Arrhythmias
-Pacing, Defibrillators & Cardiac Resynchronisation Therapy
-Sudden Cardiac Death
-Ventricular Arrhythmias
Guidelines & Statements
Heart Failure
-Heart Failure Diagnosis and Imaging
-Chronic Heart Failure Management
--Symptom and Congestion Management
--HFrEF Pharmacological Management
--HFpEF Pharmacological Management
--HFmrEF Pharmacological Management
-Acute and Advanced Heart Failure
--Advanced Heart Failure and Transplant
-Heart Failure Devices
-Cardiomyopathies and Cardiac Amyloidosis
--Cardiac Amyloidosis
--Cardiomyopathies
---Other Cardiomyopathies
---Hypertrophic Cardiomyopathy
-Heart Failure Comorbidities
--Heart Failure and Diabetes
--Heart Failure and Chronic Kidney Disease
--Heart Failure and Atrial Fibrillation
--Heart Failure and Iron Deficiency
--Heart Failure and Cancer
--Heart Failure and Obesity
-Equity, Age, Sex, and Reproduction
--Heart Failure in Older Adults
--Heart Failure in Women
--Heart Failure in Pregnancy and Postpartum
-Heart Failure Services, Prevention and Digital Health
--Medication Optimisation and Titration
--Remote Monitoring and Telehealth
--Digital Health and Artificial Intelligence
Pericardium Disorders
Newer than
Worldwide Expansion of Chagas Disease
Monomorphic Ventricular Arrhythmias in the Setting of Arrhythmogenic Right Ventricular Cardiomyopathy
Flow Diagram of Proposed Evaluation for Athletes with Monomorphic Ventricular Arrhythmias
Diagnosing Subclinical Left Ventricular Dysfunction During Chemotherapy Before Heart Failure Occurrence
Summary of Angiotensin-converting Enzyme Inhibitor and/or Beta-blocker in the Primary Prevention of Cardiotoxicity Before Chemotherapy
Overview of Unfavourable and Favourable<br /> Effects of SGLT2i in Patients with Type 2 Diabetes
Differential Treatment Effects of SGLT2i
SGLT2i Treatment Effects
Assessment of Eligibility for Advanced Heart<br /> Failure Treatment Versus Indications for Referral to a<br /> Specialised Heart Failure Centre
Survival by Number of Risk Factors for New York<br /> Heart Association Class III–IV, with Ejection Fraction <40%
Triggers for Referral for Advanced Therapy
Abiomed Impella RP System
Pagination
First page
«
Previous page
‹
Page
101
Page
102
Page
103
Page
104
Page
105
Page
106
Page
107
Page
108
Page
109
Next page
›
Last page
»